Open Access
ARTICLE
miRNA-214 Inhibits Cellular Proliferation and Migration in Glioma Cells Targeting Caspase 1 Involved in Pyroptosis
* Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, P.R. China
† Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, P.R. China
‡ Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, P.R. China
§ Department of Neurosurgery, Harbin Medical University Cancer Hospital, Harbin, P.R. China
¶ Bio-X Center, School of Life Science and Technology, Harbin Institute of Technology, Harbin, P.R. China
# Orthopedic Hospital Research Center, University of California, Los Angeles, CA, USA
** Department of Pathology and Laboratory Medicine, David Geffen School of Medicine,
University of California, Los Angeles, CA, USA
†† Department of Operating Room, The First Affiliated Hospital of Harbin Medical University, Harbin, P.R. China
1
These authors provided equal contribution to this work as first authors.
Oncology Research 2017, 25(6), 1009-1019. https://doi.org/10.3727/096504016X14813859905646
Abstract
Pyroptosis is a type of proinflammatory programmed cell death mediated by caspase 1 activity and occurs in several types of eukaryotic tumor cells, including gliomas. MicroRNAs (miRNAs), small endogenous noncoding RNAs, have been demonstrated to be advantageous in glioma therapy. However, the question of whether miRNAs regulate pyroptosis in glioma remains unknown. The current study found that caspase 1 expression was substantially increased in both glioma tissues and glioma cell lines, U87 and T98G, while miR-214 expression was significantly downregulated. Luciferase reporter assay recognized caspase 1 as a target gene of miR-214. These findings demonstrate that miR-214 could inhibit cell proliferation and migration through the regulation of pyroptosis intermediated by caspase 1 in glioma U87 and T98G cells and may suggest a novel therapeutic for the intervention of glioma.Keywords
Cite This Article
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.